Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
BJU International
|
May 18, 2018
Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer
Jinge Zhao, Guangxi Sun, Banghua Liao, et al.
The Prostate
|
July 12, 2019
AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy
Jinge Zhao, Mengni Zhang, Jiandong Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2025
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and Adolescents
Haoyang Liu, Haolin Liu, Junru Chen, et al.
Molecular Cancer
|
June 26, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma
Junjie Zhao, Yanfeng Tang, Xu Hu, et al.
BMC Medicine
|
July 21, 2022
Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
Sha Zhu, Jinge Zhao, Ling Nie, et al.
Quantitative Imaging in Medicine and Surgery
|
July 29, 2025
Predicting pathogenic DNA damage repair gene mutations in prostate cancer patients: a multi-center magnetic resonance imaging radiomics study
Yuntian Chen, Jinge Zhao, Lei Ye, et al.
Journal of Multidisciplinary Healthcare
|
March 3, 2023
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients
Yuhao Zeng, Sha Zhu, Zilin Wang, et al.
BJU International
|
June 29, 2021
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate
Jinge Zhao, Guangxi Sun, Sha Zhu, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge
Yanfeng Tang, Junru Chen, Jue Hu, et al.
Journal of Cancer Research and Clinical Oncology
|
March 13, 2023
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer
Nanwei Xu, Jinge Zhao, Fengnian Zhao, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
BJU International
|
May 18, 2018
Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer
Jinge Zhao, Guangxi Sun, Banghua Liao, et al.
The Prostate
|
July 12, 2019
AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy
Jinge Zhao, Mengni Zhang, Jiandong Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2025
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and Adolescents
Haoyang Liu, Haolin Liu, Junru Chen, et al.
Molecular Cancer
|
June 26, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma
Junjie Zhao, Yanfeng Tang, Xu Hu, et al.
BMC Medicine
|
July 21, 2022
Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
Sha Zhu, Jinge Zhao, Ling Nie, et al.
Quantitative Imaging in Medicine and Surgery
|
July 29, 2025
Predicting pathogenic DNA damage repair gene mutations in prostate cancer patients: a multi-center magnetic resonance imaging radiomics study
Yuntian Chen, Jinge Zhao, Lei Ye, et al.
Journal of Multidisciplinary Healthcare
|
March 3, 2023
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients
Yuhao Zeng, Sha Zhu, Zilin Wang, et al.
BJU International
|
June 29, 2021
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate
Jinge Zhao, Guangxi Sun, Sha Zhu, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge
Yanfeng Tang, Junru Chen, Jue Hu, et al.
Journal of Cancer Research and Clinical Oncology
|
March 13, 2023
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer
Nanwei Xu, Jinge Zhao, Fengnian Zhao, et al.
Page
of 10